Topical Pancreatic Duct Lidocaine for Prevention of Post-ERCP Pancreatitis

NCT00953199 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

506

Enrollment

OTHER

Sponsor class

Conditions

Pancreatitis

Interventions

DRUG: Lidocaine Hydrochloride
DRUG: Normal Saline

Sponsor

Abraham Mathew MD

Collaborators

[object Object]